Adjuvant tamoxifen for male breast cancer

Dec 8, 2021 · Eggemann H, Ignatov A, Smith BJ, Altmann U, von Minckwitz G, Rohl FW, Jahn M. However, endocrine therapy for men with HR+/HER2-negative breast cancer is typically tamoxifen in the adjuvant or metastatic settings

2024-03-28
    5 tizanidine hcl
  1. The median follow-up was 42
  2. It’s a treatment for: early breast cancer
  3. Men presenting hormone receptor-positive breast cancer who are
  4. Perkins, S
  5. Patients were enrolled without knowledge of hormone receptor status
  6. 21